ACRO Establishing CRO Forum To Interact With TransCelerate BioPharma Inc.

WASHINGTON--(BUSINESS WIRE)--October 27, 2014--The Association of Clinical Research Organizations today announced plans to constitute a CRO Forum in order to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma Inc. The CRO Forum, expected to commence operation in January 2015, is open to all CROs and participation is included as a benefit of ACRO membership.

“ACRO welcomes this opportunity to provide meaningful input on TransCelerate projects of interest to the CRO community,” said Ciaran Murray, ACRO Chairman and CEO of ICON plc. “We have maintained a cordial but informal relationship with TransCelerate since its formation in late 2012. As CROs in general, and ACRO members in particular, are often at the forefront of implementing the innovations advanced by TransCelerate’s members, we believe the time is right for more direct interaction. We will be reaching out to the broader CRO community to gauge interest in participating in the Forum.”

The CRO Forum will provide subject matter experts from participating CROs as liaisons to relevant TransCelerate workstreams. Forum representatives shall be kept apprised of workstream developments and furnish a CRO perspective on projects. The CRO Forum’s charter may be accessed here and interested CROs may contact ACRO by email at [email protected] or by phone.

“We are pleased to work with ACRO and the CRO Forum to provide key stakeholder input into our ongoing and future projects,” said Jonathan Zung, PhD, Vice President and Head Global Clinical Sciences and Operations, UCB and Operations Committee Chair for TransCelerate. “We look forward to open dialogue as we shape industry-wide solutions. Beyond the regular interactions between TransCelerate member companies and their CRO partners, the CRO Forum will serve as TransCelerate’s primary method of interaction with the wider CRO industry.”

About ACRO

The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 100,000 professionals worldwide and conduct research in 142 countries. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook. RebelMouse.

[email protected]Contacts
Association of Clinical Research Organizations (ACRO)
John Lewis, 202-464-9340
[email protected]